← Browse by Condition
Medical Condition
stage iv prostate cancer ajcc v8
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2
NCT05487846
Recruiting
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Enrollment
120 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT05054296 Phase 2
Recruiting
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
Enrollment
200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05869682 Phase 2
Recruiting
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
Enrollment
210 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05168618 Phase 2
Recruiting
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Enrollment
33 pts
Location
United States
Sponsor
University of Utah